norovirus and semaglutide Weight-loss company Noom pivots to smaller doses of compounded Wegovy New Strain of Norovirus May

The lawsuit did not proceed to injunctive relief or consent order before the administration change in January 2025, and the new FTC leaderships approach to the litigation remains an active area of uncertainty as of Q1 2026

We provide access to various treatments based on clinical eligibility, including compounded semaglutide and compounded tirzepatide

Selective endpoint reporting: Studies showing any positive metabolic effectimproved insulin sensitivity, modest glucose reductionsbecome evidence that the supplement works, even when the measured outcome differs entirely from what consumers expect based on pharmaceutical comparisons

Hyperglycemia as a risk factor in pancreatic cancer: A nested case-control study using prediagnostic blood glucose levels

March 9, 2026